LEI: 213800WTQKOQI8ELD692


OneSavings Bank plc
(the Company)

NOTICE OF ANNUAL GENERAL MEETING

The following regulated information, disseminated pursuant to DTR 6.3.5, comprises the Notice of Annual General Meeting for 2020 which was sent to shareholders of the Company on 31 March 2020. A copy of the Notice of Annual General Meeting is available at www.osb.co.uk

As a result of the current outbreak of Coronavirus (COVID-19), and in line with the latest restrictions on public gatherings imposed by the UK Government, the Company wishes to notify shareholders that attendance at the Annual General Meeting in person will not be possible.

Enquiries:

OneSavings Bank plc
Nickesha Graham-Burrell
Head of Company Secretariat                                        t: 01634 835 796

Brunswick                                                                    t:  020 7404 5959
Robin Wrench / Simone Selzer

Notes to Editors

About OneSavings Bank plc

OneSavings Bank plc (OSB) began trading as a bank on 1 February 2011 and was admitted to the main market of the London Stock Exchange in June 2014 (OSB.L). OSB joined the FTSE 250 index in June 2015. On 4 October 2019, OSB acquired Charter Court Financial Services Group plc (CCFS) and its subsidiary businesses. OSB is a specialist lending and retail savings Group authorised by the Prudential Regulation Authority, part of the Bank of England, and regulated by the Financial Conduct Authority and Prudential Regulation Authority.

OneSavings Bank

OSB primarily targets market sub-sectors that offer high growth potential and attractive risk-adjusted returns in which it can take a leading position and where it has established expertise, platforms and capabilities. These include private rented sector Buy-to-Let, commercial and semi-commercial mortgages, residential development finance, bespoke and specialist residential lending, secured funding lines and asset finance.

OSB originates mortgages organically via specialist brokers and independent financial advisers through its specialist brands including Kent Reliance for Intermediaries, InterBay Commercial and Prestige Finance. It is differentiated through its use of highly skilled, bespoke underwriting and efficient operating model.

OSB is predominantly funded by retail savings originated through the long-established Kent Reliance name, which includes online and postal channels as well as a network of branches in the South East of England. Diversification of funding is currently provided by securitisation programmes, the Term Funding Scheme and the Bank of England Indexed Long-Term Repo operation.

Charter Court Financial Services Group

CCFS focuses on providing Buy-to-Let and specialist residential mortgages, mortgage servicing, administration and credit consultancy and retail savings products. It operates through its three brands – Precise Mortgages, Exact Mortgage Experts and Charter Savings Bank.

It is differentiated through risk management expertise and best-of-breed automated technology and systems, ensuring efficient processing, strong credit and collateral risk control and speed of product development and innovation. These factors have enabled strong balance sheet growth whilst maintaining high credit quality mortgage assets.

CCFS is predominantly funded by retail savings originated through its Charter Savings Bank brand. Diversification of funding is currently provided by securitisation programmes, the Term Funding Scheme and the Bank of England Indexed Long-Term Repo operation.

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to what action you should take, you are recommended to seek your own personal financial advice immediately from your stockbroker, bank manager, solicitor, accountant or other independent financial adviser who, if you are taking advice in the United Kingdom, is duly authorised under the Financial Services and Markets Act 2000, or an appropriately authorised independent financial adviser if you are in a territory outside the United Kingdom.

If you have sold or transferred all of your ordinary shares in OneSavings Bank plc, please send this document and any other documents that accompany it as soon as possible to the purchaser or transferee or to the stockbroker, bank or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee. If you have sold or otherwise transferred only part of your holding, you should retain this document and its enclosures.

Notice of Annual General Meeting

(incorporated and registered in England and Wales under number 07312896. Registered office: Reliance House, Sun Pier, Chatham, Kent ME4 4ET)

Notice of Annual General Meeting on Thursday, 7 May 2020 at 11 am at 90 Whitfield Street, Fitzrovia, London W1T 4EZ

LETTER FROM THE CHAIRMAN

31 March 2020

Dear Shareholder

2019 ANNUAL REPORT AND ACCOUNTS AND 2020 ANNUAL GENERAL MEETING
I am pleased to inform you that the Annual Report and Accounts for the year ended 31 December 2019 and the Notice of the 2020 Annual General Meeting of OneSavings Bank plc (the ‘Company’) have now been published. A copy of the 2019 Annual Report and Accounts is enclosed with this document, together with a Form of Proxy to enable you to exercise your voting rights at the Annual General Meeting (‘AGM’).

The AGM will be held at 90 Whitfield Street, Fitzrovia, London W1T 4EZ on Thursday, 7 May 2020 at 11 am. Please disregard the AGM venue details included in the 2019 Annual Report and Accounts.

The formal notice of the AGM is set out on pages 2 to 4 of this document and contains the proposed Resolutions. Explanatory notes to the business to be considered are set out from page 5 of this document.

DIRECTORS’ REMUNERATION
The Current Directors’ Remuneration Policy was approved at the AGM in May 2018 and we had planned to operate it for the full three years. However, as a result of the Combination, we need to seek shareholder approval for a new Remuneration Policy in line with the more stringent regulatory requirements applicable to Financial Conduct Authority Level 2 firms. Shareholders will be asked to approve three resolutions on Directors’ remuneration at the AGM: the Directors’ Remuneration Report; the Directors’ Remuneration Policy and a cap on variable remuneration for individuals whose remuneration is regulated by the Prudential Regulation Authority’s Remuneration Code.

VOTING AT THE AGM
I will, once again, be inviting you to vote on all Resolutions at the AGM by way of a poll rather than on a show of hands. Poll voting is in line with practice adopted by many UK public companies and provides a more transparent method of voting. It will result in a more accurate reflection of the views of shareholders by ensuring that every vote is recognised, including the votes of those shareholders who are unable to attend but who have appointed a proxy for the meeting. On a poll, each shareholder has one vote for every share held. I would encourage shareholders to exercise their right to vote and due to the unprecedented circumstances surrounding the Coronavirus (COVID-19), you should do so by completing your Form of Proxy as outlined below.

ACTION TO BE TAKEN
Please complete and return the enclosed Form of Proxy so that it is received by the Company’s Registrar, Equiniti, by no later than 11 am on Tuesday, 5 May 2020. If you are a member of CREST, you may submit a proxy appointment electronically through the CREST voting service. Further details are set out in the Notes section on page 9.

The results of voting on the Resolutions will be announced to the London Stock Exchange and posted on the Company’s website following the conclusion of the AGM.

RECOMMENDATION
The Directors recommend shareholders to vote in favour of each of the Resolutions at the AGM. The Board considers that the Resolutions are in the best interests of the Company’s shareholders as a whole and will promote the success of the Company for their benefit. The Directors intend to vote in favour of the Resolutions in respect of their own beneficial shareholdings in the Company (save in respect of those Resolutions in which they are interested).

As a result of the current outbreak of Coronavirus (COVID-19), and in line with the latest restrictions on public gatherings imposed by the UK Government, the Company wishes to notify shareholders that attendance at the AGM in person will not be possible.

Yours faithfully

David Weymouth
Chairman

NOTICE OF ANNUAL GENERAL MEETING
Notice is hereby given that the Annual General Meeting of OneSavings Bank plc (the ‘Company’) will be held at 90 Whitfield Street, Fitzrovia, London W1T 4EZ on Thursday, 7 May 2020 at 11 am to consider and, if thought fit, pass the following Resolutions.

Resolutions 1 to 3 and 5 to 11 will be proposed as ordinary resolutions. Resolutions 12 to 16 will be proposed as special resolutions.

Resolution 4 will be proposed as a resolution with the voting thresholds specified in the explanatory notes accompanying this Notice.

1.    To receive the audited financial statements and the Auditor’s and Directors’ reports for the year ended 31 December 2019.

2.    To approve the Directors’ Remuneration Report (excluding the Directors’ Remuneration Policy) for the year ended 31 December 2019.

3.    To approve the Directors’ Remuneration Policy (as set out in the Directors’ Remuneration Report for the year ended 31 December 2019).

4.    That the Company and its subsidiaries are authorised to apply a ratio in relation to the fixed and variable components of remuneration for individuals whose remuneration is regulated by the Prudential Regulation Authority’s Remuneration Code, such that the variable component of total remuneration for such an individual does not exceed 200 per cent. of the fixed component of the total remuneration for that individual.

5.    To declare a final dividend of 11.2 pence per ordinary share in respect of the year ended 31 December 2019.

6.    Election and re-election of Directors.

To elect by separate resolutions each of the following as a Director of the Company: 

Independent Non-Executive Directors
(a)        Noël Harwerth
(b)        Rajan Kapoor
           
To re-elect by separate resolutions each of the following as a Director of the Company:

Non-Executive Director
(c)        David Weymouth

Independent Non-Executive Directors
(d)        John Graham Allatt
(e)        Sarah Hedger
(f)         Mary McNamara

Executive Directors
(g)        Andrew Golding
(h)        April Talintyre

7.    To re-appoint Deloitte LLP as the Auditor of the Company.

8.    To authorise the Group Audit Committee to agree the remuneration of the Auditor.

9.    That, in accordance with sections 366 and 367 of the Companies Act 2006 (the ‘Act’), the Company and all companies that are its subsidiaries, at any time up to the close of business on 30 June 2021 or, if earlier, the conclusion of the Annual General Meeting of the Company to be held in 2021, are authorised to:
a.    make political donations to political parties and/or independent election candidates;
b.    make political donations to political organisations other than political parties; and
c. incur political expenditure;

up to an aggregate total amount of £50,000, with the amount authorised for each of heads (a) to (c) above being limited to the same total.

For the purposes of this authority the terms ‘political donation’, ‘political parties’, ‘independent election candidates’, ‘political organisation’ and ‘political expenditure’ have the meanings given by sections 363 to 365 of the Act as at the date of this notice of meeting.

10.   That the Directors are generally and unconditionally authorised pursuant to and in accordance with section 551 of the Companies Act 2006 (the ‘Act’) to exercise all the powers of the Company to allot shares in the Company and to grant rights to subscribe for, or to convert any security into, shares in the Company (‘Rights’):
a.    up to a maximum aggregate nominal amount of £1,487,339; and
b.    comprising equity securities (within the meaning of section 560 of the Act) up to a further maximum aggregate nominal amount of £1,487,339 in connection with an offer by way of a rights issue:
(i)       to ordinary shareholders in proportion (as nearly as may be practicable) to their existing holdings; and
(ii)       to the holders of other equity securities, as required by the rights of those securities or as the Directors otherwise consider necessary

and subject to such exclusions or other arrangements as the Directors may deem necessary or expedient to deal with treasury shares, fractional entitlements, record dates or legal, regulatory or practical problems arising under the laws or the requirements of any regulatory body or stock exchange in any territory or by virtue of shares being represented by depositary receipts or any other matter.

This authority shall expire at the close of business on 30 June 2021 or, if earlier, at the conclusion of the Annual General Meeting of the Company to be held in 2021, save that the Company shall be entitled to make offers or agreements before the expiry of such authority which would or might require shares to be allotted or Rights to be granted after such expiry and the Directors shall be entitled to allot shares and grant Rights pursuant to any such offer or agreement as if this authority had not expired; and all authorities vested in the Directors on the date of the notice of this meeting to allot shares and grant Rights that remain unexercised at the commencement of this meeting are hereby revoked.

11.   That, in addition to the authority contained in Resolution 10 in the notice of this meeting, the Directors are generally and unconditionally authorised pursuant to and in accordance with section 551 of the Companies Act 2006 (the ‘Act’) to exercise all the powers of the Company to allot shares in the Company and to grant rights to subscribe for, or to convert any security into, shares in the Company:
a.    up to a maximum aggregate nominal amount of £535,442 in relation to the issue of Regulatory Capital Convertible Instruments; and
b.    subject to applicable law and regulation, at such conversion prices (or such maximum or minimum conversion prices or conversion price methodologies) as may be determined by the Directors of the Company from time to time.

This authority shall expire at the close of business on 30 June 2021 or, if earlier, at the conclusion of the Annual General Meeting of the Company to be held in 2021, save that the Company shall be entitled to make offers or agreements before the expiry of such authority which would or might require shares to be allotted or rights to be granted after such expiry and the Directors may allot shares and grant rights to subscribe for or to convert any security into shares, in pursuance of any such offer or agreement as if the authority had not expired.

12.   That, subject to the passing of Resolution 10 in the notice of this meeting, the Directors are empowered pursuant to sections 570 and 573 of the Companies Act 2006 (the ‘Act’) to allot equity securities (within the meaning of section 560 of the Act) for cash either pursuant to the authority conferred by Resolution 10 in the notice of this meeting and/or by way of a sale of treasury shares as if section 561(1) of the Act did not apply to any such allotment or sale provided that this power shall be limited to:
a.    the allotment of equity securities and/or the sale of treasury shares in connection with an offer of or invitation to acquire equity securities (but in the case of the authority granted under sub-paragraph (b) of Resolution 10 in the notice of this meeting by way of a rights issue only):
(i)       to the holders of ordinary shares in proportion (as nearly as may be practicable) to their existing holdings; and
(ii)       to the holders of other equity securities, as required by the rights of those securities or as the Directors otherwise consider necessary, and subject to such exclusions or other arrangements as the Directors may deem necessary or expedient to deal with treasury shares, fractional entitlements, record dates or legal, regulatory or practical problems arising under the laws of or the requirements of any regulatory body or stock exchange in any territory or by virtue of shares being represented by depositary receipts or any other matter; and
b.    the allotment of equity securities and/or sale of treasury shares (otherwise than pursuant to sub-paragraph (a) of this Resolution 12) to any person or persons up to a maximum aggregate nominal amount of £223,101.

Such power shall expire on the revocation or expiry (unless renewed) of the general authority conferred on the Directors by Resolution 10 in the notice of this meeting, save that the Company shall be entitled to make offers or agreements before the expiry of such power which would or might require equity securities to be allotted after such expiry and the Directors shall be entitled to allot equity securities pursuant to any such offer or agreement as if the power conferred hereby had not expired.

13.   That, subject to the passing of Resolution 10 in the notice of this meeting and in addition to the power contained in Resolution 12 in the notice of this meeting, the Directors are empowered pursuant to sections 570 and 573 of the Companies Act 2006 (the ‘Act’) to allot equity securities (within the meaning of section 560 of the Act) for cash pursuant to the authority conferred by Resolution 10 in the notice of this meeting and/or by way of a sale of treasury shares as if section 561(1) of the Act did not apply, provided that this power is:
a.    limited to the allotment of equity securities and/or sale of treasury shares up to an aggregate nominal value of £223,101; and
b.    used only for the purposes of financing (or refinancing, if the power is to be exercised within six months after the date of the original transaction) a transaction which the Directors determine to be an acquisition or other capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of the notice of this meeting.

Such power shall expire on the revocation or expiry (unless renewed) of the authority conferred on the Directors by Resolution 10 in the notice of this meeting, save that the Company shall be entitled to make offers or agreements before the expiry of such power which would or might require equity securities to be allotted after such expiry and the Directors shall be entitled to allot equity securities pursuant to any such offer or agreement as if the power conferred hereby had not expired.

14.   That, subject to the passing of Resolution 11 in the notice of this meeting and in addition to the powers contained in Resolutions 12 and 13 in the notice of this meeting, the Directors are empowered pursuant to sections 570 and 573 of the Companies Act 2006 (the ‘Act’) to allot equity securities (within the meaning of section 560 of the Act) for cash either pursuant to the authority conferred by Resolution 11 in the notice of this meeting and/or by way of a sale of treasury shares as if section 561 of the Act did not apply to any such allotment or sale.

 Such power shall expire on the revocation or expiry (unless renewed) of the authority conferred on the Directors by Resolution 11 in the notice of this meeting, save that the Company shall be entitled to make offers or agreements before the expiry of such power which would or might require equity securities to be allotted after such expiry and the Directors shall be entitled to allot equity securities pursuant to any such offer or agreement as if the power conferred hereby had not expired.

15.   That the Company is generally and unconditionally authorised for the purpose of section 701 of the Companies Act 2006 (the ‘Act’) to make market purchases (within the meaning of section 693(4) of the Act) of ordinary shares in the capital of the Company on such terms and in such manner as the Directors may from time to time determine, provided that:
a.    the maximum aggregate number of ordinary shares hereby authorised to be acquired is 44,620,136;
b.    the minimum price (excluding expenses) which may be paid for any such share is its nominal value;
c.    the maximum price (excluding expenses) which may be paid for any such share is the higher of (i) an amount equal to 5% above the average of the middle market quotations for an ordinary share in the Company as derived from The London Stock Exchange Daily Official List for the 5 business days immediately preceding the day on which such share is contracted to be purchased; and (ii) the higher of the price of the last independent trade of an ordinary share and the highest current independent bid for an ordinary share in the Company on the trading venues where the market purchases by the Company is carried out;
d.    the authority hereby conferred shall expire at the close of business on 30 June 2021 or, if earlier, at the conclusion of the Annual General Meeting of the Company to be held in 2021 unless previously renewed, varied or revoked by the Company in general meeting; and
e.    the Company may, before this authority expires, make a contract to purchase its ordinary shares which would or might be executed wholly or partly after the expiry of this authority, and may purchase its ordinary shares pursuant to it as if this authority had not expired.
16.   That a general meeting of the Company, other than an Annual General Meeting, may be called on not less than 14 clear days’ notice.

By Order of the Board

Jason Elphick
Group General Counsel and Company Secretary 31 March 2020
Registered Office:
Reliance House
Sun Pier
Chatham
Kent ME4 4ET

EXPLANATORY NOTES
Information about the business to be considered at the AGM is set out below.

These explanatory notes should be read in conjunction with the 2019 Annual Report and Accounts. This Notice of AGM and the 2019 Annual Report and Accounts are available at www.osb.co.uk. For the purpose of this Notice, the issued share capital of the Company with voting rights on 27 March 2020, being the latest practicable date prior to the printing of this document, was 446,201,355 ordinary shares of £0.01 each.

RESOLUTION 1: 2019 Annual Report and Accounts (ordinary resolution)
The Directors of the Company present the Directors’ reports, the Auditor’s report and the audited financial statements of the Company for the financial year ended 31 December 2019 (the ‘2019 Annual Report and Accounts’) to the AGM as required by the Companies Act 2006.

The Company proposes an ordinary resolution to receive the 2019 Annual Report and Accounts and, accordingly, shareholders have the opportunity to raise any questions on those documents under this Resolution.

RESOLUTION 2: Directors’ Remuneration Report (excluding the Remuneration Policy) for the year ended 31 December 2019 (ordinary resolution)
In accordance with the Companies Act 2006, shareholders are invited to approve the Directors’ Remuneration Report for the year ended 31 December 2019. This consists of the Annual Statement from the Chair of the Group Remuneration Committee and the Annual Report on Remuneration, which may be found on pages 122 to 126 and 135 to 144 of the 2019 Annual Report and Accounts. It details the Directors’ remuneration for the year ended 31 December 2019 and sets out the way in which the Company intends to implement the proposed new Directors’ Remuneration Policy in 2020. The Auditor has audited those parts of the Directors’ Remuneration Report required to be audited and its report can be found on pages 150 to 161 of the 2019 Annual Report and Accounts. For the purposes of this Resolution, the Directors’ Remuneration Report does not include the Directors’ Remuneration Policy which is the subject of a separate vote at Resolution 3. The vote on Resolution 2 is advisory only and the Directors’ entitlement to remuneration is not conditional on it being passed.

RESOLUTION 3: Directors’ Remuneration Policy (ordinary resolution)
In accordance with the Companies Act 2006, the Directors’ Remuneration Policy (the ‘Policy’) is required to be put to shareholders for approval annually unless the approved Policy remains unchanged, in which case it need only be put to shareholders for approval at least every three years. The Policy was last approved by shareholders at the Company’s AGM held in 2018. As changes are now proposed to the Policy, it is subject to approval by shareholders at the 2020 AGM. The vote on the new Policy is by way of ordinary resolution. It is a binding vote, meaning that payments to Directors may only be made if they are within the boundaries of the approved Policy. The new Policy sets out how the Company proposes to pay the Directors, including every element of remuneration to which a Director may be entitled, as well as how the Policy supports the Company’s long-term strategy and performance. It also includes details of the Company’s approach to recruitment and payment for loss of office. Once approved, the Company will only be able to make remuneration payments to current and prospective Directors and payments for loss of office to current or past Directors within the boundaries of the new Policy, unless an amendment to the Policy authorising the Company to make such payments has been approved by a separate shareholder resolution.
If approved by shareholders, the new Policy will apply from the conclusion of the AGM and it is currently intended that it will apply for three years until the AGM in 2023 when further shareholder approval will be sought.

RESOLUTION 4: Variable component of remuneration for Code Staff
The EU Capital Requirements Directive IV, together with rules made by the Prudential Regulation Authority (‘PRA’) that implement the Directive in the UK, place a limit on the ratio of the fixed to variable components of total remuneration for Remuneration Code Staff (being those individuals who have a material impact on the Group’s risk profile). Under the PRA Remuneration Code, the variable element of remuneration for such individuals is capped at 100 per cent. of fixed remuneration. That cap may, however, be increased to no more than 200 per cent. Shareholder approval is required to do this.
At the AGM, the Company is seeking shareholder approval to increase the limit to permit it to award variable remuneration of up to a maximum of 200 per cent. of fixed remuneration. The Group Remuneration Committee strongly believes in pay for performance, in providing a competitive package that allows the Company to attract and retain the key talent necessary to deliver the strategy set by the Board, and in ensuring that fixed costs are appropriately managed whilst ensuring that variable pay does not incentivise inappropriate risk taking. The approval sought by this Resolution will enable to Company to do this. It will also enable the Company to defer a larger quantum of variable pay that could be subject to performance adjustment (i.e. a reduction or cancellation of unvested awards, if appropriate) than would be the case if the variable component of remuneration was restricted to up to 100 per cent. of the fixed component of remuneration.

The cap is relevant only to the Group’s Code Staff. The Group’s Code Staff represents only a small percentage (less than 3 per cent.) of the Group’s employees. It is not anticipated that the passing of this Resolution will have any impact on the Group’s ability to maintain a sound capital base.

The PRA Remuneration Code requires that in order for the cap on variable remuneration to be increased, it must be approved by a majority of at least 66 per cent. of the shares represented (in person or by proxy) at the AGM, provided that at least 50 per cent. of the total shares in the Company are represented at the meeting. Where less than 50 per cent. of the total shares in the Company are represented at the meeting, the increase must be approved by a majority of at least 75 per cent. of the shares represented (in person or by proxy) at the meeting.

Employees who have an interest in the increased limit in respect of variable remuneration are not allowed to, and will be instructed not to, exercise, directly or indirectly, any voting rights they may hold as shareholders in respect of this Resolution.

RESOLUTION 5: Final dividend (ordinary resolution)
A final dividend of 11.2 pence per ordinary share has been recommended by the Board for the year ended 31 December 2019 and, if approved by shareholders, will be paid on 13 May 2020 to all shareholders on the register at the close of business on 27 March 2020.

RESOLUTIONS 6 (a) to (h): Election and re-election of Directors (ordinary resolutions)
Resolutions 6 (a) to (h) relate to the retirement and election or re-election of the Company’s Directors. The Company’s articles of association require a Director who has been appointed by the Board during the year to retire at the AGM next following his or her appointment. Noël Harwerth and Rajan Kapoor have each been appointed since the date of the Company’s last AGM. Consequently, they will retire from office at the AGM and are seeking election by shareholders. Timothy Brooke, Margaret Hassall and Ian Ward will not seek election or re-election at the AGM.

The Company’s articles of association also require any Director who has not been elected or re-elected by the Company’s shareholders at either of the two preceding Annual General Meetings to retire at the next AGM. Notwithstanding the provisions of the Company’s articles of association, the Board has determined that, in line with best practice recommendations of the Financial Reporting Council’s UK Corporate Governance Code, each of the remaining Directors shall retire from office at the AGM and each shall stand for re-election by the shareholders.

The Board has confirmed, following a performance review, that each of the Directors standing for election and re-election continues to be an effective member of the Board, to make a positive contribution and to demonstrate commitment to his or her role. The Board believes that the considerable and wide-ranging experience of the Directors will continue to be invaluable to the Company. The biographies of Directors can be found in the Appendix to this document and also on the Company’s website www.osb.co.uk.

RESOLUTIONS 7 AND 8: Re-appointment and remuneration of the Auditor (ordinary resolutions)
The Company is required to appoint an auditor at each general meeting at which accounts are laid before the Company, to hold office until the conclusion of the next such meeting. The Group Audit Committee has recommended to the Board the re-appointment of Deloitte LLP as Auditor of the Company and has confirmed to the Board that its recommendation is free from third party influence and that no restrictive contractual provisions have been imposed on the Company limiting the choice of auditor. Resolution 7 proposes the re-appointment of Deloitte LLP as the Auditor of the Company and Resolution 8 authorises the Group Audit Committee to agree the Auditor’s remuneration.

RESOLUTION 9: Authority to make political donations (ordinary resolution)
In line with the Group’s policy, neither the Company nor any of its subsidiaries made any political donations nor incurred any political expenditure during 2019. It is not proposed or intended to alter this policy. However, some of the Group’s activities may potentially fall within the wide definitions of ‘political donation’ or ‘political expenditure’ in the Companies Act 2006 and, without the necessary statutory authorisation, the Group’s ability to communicate its views effectively to political audiences and to relevant interest groups could be inhibited. Such activities may include briefings at receptions or conferences – when the Group seeks to communicate its views on issues vital to its business interests – including, for example, conferences of a party political nature or of special interest groups in specific areas.

Accordingly, the Company believes that the authority contained in this Resolution is necessary to allow it and its subsidiaries to fund activities which it is in the interests of shareholders that the Company should support. Such authority will enable the Company and its subsidiaries to be sure that they do not, because of any uncertainty as to the bodies or the activities covered by the Companies Act 2006, unintentionally commit a technical breach of the statutes. Any political donation made or expenditure incurred under authority of this Resolution will be disclosed in next year’s Annual Report and Accounts.

RESOLUTION 10: Directors’ authority to allot shares (ordinary resolution)
The Directors currently have a general authority to allot new ordinary shares in the capital of the Company and to grant rights to subscribe for, or convert any securities into, shares. This authority is, however, due to expire at the AGM and the Board would like to renew it to provide the Directors with flexibility to allot new shares and grant rights up until the Company’s next AGM within the limits prescribed by The Investment Association.

The Investment Association’s guidelines on Directors’ authority to allot shares state that the Association’s members will regard as routine any proposal at a general meeting to seek a general authority to allot an amount up to two-thirds of the existing share capital, provided that any amount in excess of one-third of the existing share capital is applied to fully pre-emptive rights issues only. Accordingly, if passed, this resolution will authorise the Directors to allot (or grant rights over) new shares in the Company: (i) under an open offer or in other situations (including a rights issue) up to an aggregate nominal amount of £1,487,339 (representing approximately 33 per cent. of the Company’s issued ordinary share capital); and (ii) under a rights issue only, up to a further aggregate nominal amount of £1,487,339 (representing approximately 33 per cent. of the Company’s issued ordinary share capital). In each case, the reference to the Company’s issued ordinary share capital is to the issued ordinary share capital as at 27 March 2020 (being the latest practicable date prior to publication of this document).

If passed, this authority will expire at the close of business on 30 June 2021 or, if earlier, at the conclusion of the AGM to be held in 2021. The Directors have no present intention of exercising this authority, however, the Board considers it prudent to maintain the flexibility that it provides to enable the Directors to respond to any appropriate opportunities that may arise. The Company did not hold any shares in treasury as at 27 March 2020.

RESOLUTION 11: Directors’ authority to allot shares in relation to the issue of Regulatory Capital Convertible Instruments (ordinary resolution)
This Resolution renews the Directors’ authority to allot shares or grant rights to subscribe for or convert any security into ordinary shares up to an aggregate nominal amount of £535,442, in connection with the issue of ‘Regulatory Capital Convertible Instruments’. Regulatory Capital Convertible Instruments are any securities to be issued by the Company or any member of the Group, or by a Company outside of the Group with the consent of the Company or a member of the Group and which are intended on issue to form all or part of a type or class of securities, the terms of which are eligible to meet any Regulatory Capital Requirements and which are:
a.    convertible into or exchangeable for ordinary shares of the Company; or
b.    issued together with share warrants relating to ordinary shares of the Company;

and in each case, which grant to, or require, the holder of such security and/or its nominee a right or obligation (as applicable) to subscribe for such ordinary shares following a specified event relating to an actual or prospective adverse change in the capital position or viability of the Company, any member of the Group or the Group as a whole or any other event specified in the Regulatory Capital Requirements and otherwise on such terms as may be determined by the Directors of the Company or a Committee thereof upon issue.

The Board believes it is in the best interests of the Company to have the flexibility to issue Regulatory Capital Convertible Instruments at any time and from time to time. The authority sought in this Resolution will be used as considered desirable to comply with or maintain compliance with such Regulatory Capital Requirements or targets applicable to the Company. Regulatory Capital Requirements are specified by the Prudential Regulation Authority or such other authority having primary supervisory authority with respect to the Company from time to time in relation to the margin of solvency, capital resources, capital, contingent capital or buffer capital of the Company, a member of the Group or the Group taken as a whole.

The Company intends to seek to renew authority for the issuance of such Regulatory Capital Convertible Instruments on an annual basis.

The amount of this authority is, in aggregate, equivalent to approximately 12% of the issued ordinary share capital of the Company as at 27 March 2020 (being the latest practicable date before the publication of this document). No ordinary shares were held in treasury as at that date.

Resolutions 11 and 14 are intended to provide the Directors with the flexibility to authorise the issue of Regulatory Capital Convertible Instruments which contain contractual debt to equity conversion features. The Resolutions are not intended to provide authority for any future UK statutory conversion requirements as may become part of UK national law in the future, for which such authority would not be required.

The authority sought in Resolution 11 is separate and distinct from the authority sought in Resolution 10 which is the usual authority sought on an annual basis in line with guidance issued by The Investment Association. The authority sought in Resolution 11 will expire at the close of business on 30 June 2021 or, if earlier, at the conclusion of the AGM to be held in 2021.

RESOLUTIONS 12 and 13: Disapplication of statutory pre-emption rights (special resolutions)
Resolutions 12 and 13 are special resolutions which, if passed by shareholders, will enable the Directors to allot ordinary shares in the Company, and/or to sell any shares out of treasury, for cash, without first offering those shares to existing shareholders in proportion to their existing holdings.

The proposed resolutions essentially replicate the powers which were granted at last year’s AGM (and which will expire at the AGM). Such powers reflect the Statement of Principles published by The Pre-Emption Group in March 2015, which provides that a company may seek power to issue, on a non-pre-emptive basis for cash, shares in any one year representing:
(i) no more than five per cent of the company’s issued ordinary share capital; and (ii) no more than an additional five per cent of the Company’s issued ordinary share capital provided that such additional power is only used in connection with an acquisition or specified capital investment.

The 2015 Statement of Principles defines a ‘specified capital investment’ as ‘one or more specific capital investment related uses for the proceeds of an issuance of equity securities, in respect of which sufficient information regarding the effect of the transaction on the listed company, the assets, the subject of the transaction and (where appropriate) the profits attributable to them is made available to shareholders to enable them to reach an assessment of the potential return’. Items that are regarded as operating expenditure rather than capital expenditure will not typically be regarded as falling within the term ‘specified capital investment’.

In line with best practice, the Company has structured its pre-emption disapplication request as two separate resolutions. Resolution 12 is proposed as a special resolution. If this resolution is passed by shareholders, it will permit the Directors to allot ordinary shares for cash on a non pre-emptive basis both in connection with a rights issue or similar pre-emptive offer and, otherwise than in connection with any such issue, up to a maximum nominal amount of £223,101. This amount represents approximately five per cent of the Company’s issued ordinary share capital as at 27 March 2020 (being the latest practicable date prior to publication of this document). This resolution will permit the Directors to allot any such shares for cash in any circumstances (whether or not in connection with an acquisition or specified capital investment).

Resolution 13 is also proposed as a special resolution. If this resolution is passed by shareholders, it will afford the Directors an additional power to allot ordinary shares for cash on a non pre-emptive basis up to a further maximum nominal amount of £223,101. This amount also represents approximately five per cent of the Company’s issued ordinary share capital as at 27 March 2020. The Directors shall use any power conferred by Resolution 13 only in connection with an acquisition or a specified capital investment which is announced contemporaneously with the issue, or which has taken place in the preceding six month period and is disclosed in the announcement of the issue.

The Directors confirm their intention to follow the provisions of the 2015 Statement of Principles regarding cumulative usage of authorities within a rolling three year period. Those provisions state that a company should not issue shares for cash representing more than 7.5% of the company’s issued share capital in any rolling three year period, other than to existing shareholders, without prior consultation with shareholders. This limit excludes any ordinary shares issued pursuant to a general disapplication of pre-emption rights in connection with an acquisition or specified capital investment.

RESOLUTION 14: Disapplication of statutory pre-emption rights in relation to the issue of Regulatory Capital Convertible Instruments (special resolution)
Resolution 11 renews the Directors’ authority to allot shares or grant rights to subscribe for or convert any security into ordinary shares up to an aggregate nominal amount of £535,442 specifically in connection with the issue of Regulatory Capital Convertible Instruments. Resolution 14 proposes that the Directors be empowered to allot equity securities pursuant to that authority for cash, without first offering those equity securities to existing shareholders in proportion to their existing holdings. £535,442 is equivalent to approximately 12% of the issued ordinary share capital of the Company as at 27 March 2020 (being the latest practicable date before the publication of this document).

Renewing this Resolution will permit the Company the flexibility necessary to allot equity securities pursuant to any proposal to issue Regulatory Capital Convertible Instruments and, by virtue of such disapplication, without the need to comply with the pre-emption requirements of the UK statutory regime. Together with Resolution 11, Resolution 14 is intended to provide the Directors with the flexibility to issue Regulatory Capital Convertible Instruments which may convert into ordinary shares.

Conditional upon the passing of Resolutions 11 and 14, the Directors would not expect to make use of Resolutions 10 and 12 to issue Regulatory Capital Convertible Instruments, however they may do so, to the extent permissible, if deemed appropriate in light of capital requirements, market conditions and/or high demand. Any exercise of the authorities in Resolutions 10 and 12 (if passed) would be separate from, and in addition to, the exercise of powers under Resolutions 11 and 14 and would have the effect of diluting the interests of ordinary shareholders.

RESOLUTION 15: Authority to purchase own shares (special resolution)
Resolution 15 gives the Company authority to buy back its own ordinary shares in the market as permitted by the Companies Act 2006.

The authority limits the maximum number of shares that could be purchased to 44,620,136 (representing approximately 10% of the Company’s issued ordinary share capital as at 27 March 2020) and sets minimum and maximum prices at which shares may be purchased.

This authority will expire at the close of business on 30 June 2021 or, if earlier, at the conclusion of the AGM to be held in 2021. A listed company purchasing its own shares may hold those shares in treasury and make them available for re-sale as an alternative to cancelling them. Accordingly, if this Resolution is passed, the Company will have the option of holding, as treasury shares, any of its own shares that it purchases pursuant to the authority conferred. This would give the Company the ability to sell treasury shares quickly and cost-effectively and provide the Company with additional flexibility in the management of its capital base. No dividends are paid and no voting rights are attached to shares held in treasury. The Company did not hold any shares in treasury as at 27 March 2020 (being the latest practicable date before the publication of this document). As at that date, there were 2,787,893 options to subscribe for ordinary shares in the capital of the Company, representing 0.63% of the Company’s issued ordinary share capital. If the full authority conferred by this Resolution were to be exercised in full, these options would represent 0.69% of the issued ordinary share capital of the Company.

The Directors have no present intention of exercising this authority, but wish to have the flexibility to do so in the future. Shares would only be purchased if the Directors believed that to do so would result in an improvement in earnings per share and would be in the interests of shareholders generally. Any purchases of ordinary shares would be by means of market purchases on a recognised investment exchange and purchased shares would be cancelled (in which case the number of shares in issue would thereby be reduced) or, alternatively, held in treasury, depending on which course of action is considered by the Directors to be in the best interests of the shareholders at that time.

RESOLUTION 16: Notice of general meetings (special resolution)
The statutory notice period required for general meetings of the Company is at least 21 clear days unless shareholders approve a shorter notice period, which cannot however be less than 14 clear days (AGMs will continue to be held on at least 21 clear days’ notice). At last year’s AGM, shareholders passed a resolution enabling the Company to call general meetings, other than an AGM, on at least 14 clear days’ notice. This approval must be renewed at each AGM, so, in order to preserve this ability, Resolution 16 seeks such approval. It is intended that the shorter notice period would not be used as a matter of routine for such meetings but only where the flexibility is merited by the business of the meeting and is thought to be in the interests of shareholders as a whole. If given, the approval will be effective until the Company’s next AGM, when it is intended that a similar resolution will be proposed.

NOTES
1.    Only persons entered on the Register of Members of the Company at 6.30 pm on Tuesday, 5 May 2020 (or, if the AGM is adjourned, at 6.30 pm on the date which is two business days prior to the adjourned meeting) shall be entitled to attend and vote at the AGM or adjourned meeting. Changes to entries on the Register of Members after this time shall be disregarded in determining the rights of persons to attend or vote (and the number of votes they may cast) at the AGM or adjourned meeting. Employee shareholders whose remuneration is regulated by the Prudential Regulation Authority’s Remuneration Code have an interest in Resolution 4 and should not exercise, directly or indirectly, any voting rights they may have in respect of the approval sought under Resolution 4. Where possible, any votes cast by them will be disregarded.

2.    A shareholder entitled to attend and vote at the AGM may appoint another person as her/his proxy to exercise all or any of her/his rights to attend, speak and vote at the AGM. A shareholder can appoint more than one proxy in relation to the AGM, provided that each proxy is appointed to exercise the rights attached to a different share or shares held by that shareholder.

3.    A proxy does not need to be a shareholder of the Company but must attend the AGM to represent you. Your proxy could be the Chairman or another person who has agreed to attend to represent you. If you wish for a proxy to make any comments on your behalf at the AGM, you will need to appoint someone other than the Chairman of the meeting and give them the relevant instructions directly. The valid appointment of a proxy does not prevent you from attending the AGM and voting in person.

4.    A shareholder who wishes to appoint a proxy should complete the Form of Proxy which accompanies this notice and includes full details of how to appoint a proxy. If you do not have a Form of Proxy and believe that you should have one, or if you require additional Forms of Proxy, please contact Equiniti’s helpline on 0371 384 2701 (+44 121 415 7047 if calling from overseas). Lines are open between 8.30 am and 5.30 pm Monday to Friday (excluding public holidays in England and Wales). Shareholders who hold their shares in uncertificated form may use ‘the CREST voting service’ to appoint a proxy electronically, as explained below.

5.    In order to be valid, a proxy appointment must be returned (together with any power of attorney or other authority under which it is executed or a copy of the authority certified in ink by a bank, a stockbroker or a solicitor) by one of the following methods:

in hard copy form by post, by courier or by hand to the Company’s registrar at the address shown on the Form of Proxy; or
in the case of CREST members, by utilising the CREST voting service in accordance with the procedures set out in note 8 below.

       The appointment of a proxy in each case must formally be received by the Company’s registrar no later than 11 am on Tuesday, 5 May 2020.
      
You may also lodge your vote electronically online at www.sharevote.co.uk where full instructions on the procedure are given. The Voting ID, Task ID and Shareholder Reference Number printed on the Form of Proxy will be required to use this electronic proxy appointment system. Alternatively, shareholders who have already registered with Equiniti Registrars’ online portfolio service, Shareview, can appoint their proxy electronically by logging on to their portfolio at www.shareview.co.uk using their user ID and password. Once logged in, click ‘view’ on the ‘My Investments’ page. Click on the link to vote and follow the on screen instructions.
6.    To change your proxy instructions you may return a new proxy appointment using the methods set out above. Where you have appointed a proxy using the hard copy Form of Proxy and would like to change the instructions using another hard copy Form of Proxy, please contact Equiniti at Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA. The deadline for receipt of proxy appointments (see above) also applies in relation to amended instructions. Any attempt to terminate or amend a proxy appointment received after the relevant deadline will be disregarded. Where two or more valid but differing appointments of proxy are delivered or received in respect of the same share in respect of the same meeting, the one which is last delivered or received (regardless of its date, its date of sending or the date of its execution) shall be treated as replacing and revoking the other or others as regards that share. If the Company is unable to determine which is last sent, the one which is last received shall be so treated. If the Company is unable to determine either which is last sent or which is last delivered or received, none of them shall be treated as valid in respect of the relevant share(s).

7.    A copy of this notice has been sent for information only, to Nominated Persons (that is, a person who has been nominated by a shareholder to enjoy information rights under section 146 of the Companies Act 2006). The rights to appoint a proxy cannot be exercised by a Nominated Person; they can only be exercised by a shareholder. However, a Nominated Person may have a right under an agreement with the shareholder by whom s/he was nominated to be appointed as a proxy for the AGM or to have someone else so appointed. If a Nominated Person does not have such a right or does not wish to exercise it, s/he may have a right under such an agreement to give instructions to the shareholder as to the exercise of voting rights.

8.    CREST members who wish to appoint a proxy or proxies by utilising the CREST electronic proxy appointment service may do so by utilising the procedures described in the CREST Manual, which can be viewed at www.euroclear.com. CREST personal members or other CREST sponsored members, and those CREST members who have appointed a voting service provider(s), should refer to their CREST sponsor or voting service provider(s), who will be able to take the appropriate action on their behalf. In order for a proxy appointment made by means of CREST to be valid, the appropriate CREST message (a ‘CREST Proxy Instruction’) must be properly authenticated in accordance with Euroclear’s specifications and must contain the information required for such instructions, as described in the CREST Manual. The message regardless of whether it constitutes the appointment of a proxy or an amendment to the instruction given to a previously appointed proxy must, in order to be valid, be transmitted so as to be received by the issuer’s agent (ID number RA19) by 11 am on Tuesday, 5 May 2020 (the latest time(s) for receipt of proxy appointments specified in this notice). For this purpose, the time of receipt will be taken to be the time (as determined by the timestamp applied to the message by the CREST Applications Host) from which the issuer’s agent is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST. The Company may treat as invalid a CREST Proxy Instruction in the circumstances set out in the Uncertificated Securities Regulations 2001.

9.    CREST members and, where applicable, their CREST sponsors or voting service providers should note that Euroclear does not make available special procedures in CREST for any particular messages. Normal system timings and limitations will therefore apply in relation to the input of CREST Proxy Instructions. It is the responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member or sponsored member or has appointed a voting service provider(s), to procure that his CREST sponsor or voting service provider(s) take(s)) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this connection, CREST members and, where applicable, their CREST sponsors or voting service providers are referred, in particular, to those sections of the CREST Manual concerning practical limitations of the CREST system and timings.

10.   Voting on all Resolutions will be conducted by way of a poll rather than a show of hands. This is a more transparent method of voting as shareholders’ votes are to be counted according to the number of shares held. As soon as practicable following the AGM, the results of the voting will be announced via a Regulatory Information Service and also placed on the Company’s website: www.osb.co.uk/investors/ shareholder-services/agm-information/.

11.   Please note that the Company takes all reasonable precautions to ensure no viruses are present in any electronic communication it sends out but the Company cannot accept responsibility for loss or damage arising from the opening or use of any email or attachments from the Company and recommends that the shareholders subject all messages to virus checking procedures prior to use. Any electronic communication received by the Company, including the lodgment of an electronic proxy form, that is found to contain any virus will not be accepted.

12.   A shareholder of the Company, that is a corporation, may authorise a person or persons to act as its representative(s) at the AGM. In accordance with the provisions of the Companies Act 2006, each such representative may exercise (on behalf of the corporation) the same powers as the corporation could exercise if it were an individual shareholder of the Company, provided that they do not do so in relation to the same shares.

13.   Shareholders satisfying the thresholds in section 527 of the Companies Act 2006 can require the Company to publish a statement on its website setting out any matter relating to the audit of the Company’s accounts (including the Auditor’s report and the conduct of the audit) that are to be laid before the AGM that the shareholders propose to raise at the AGM. The Company may not require the shareholders requesting the publication to pay its expenses. Any statement placed on the website must also be sent to the Company’s Auditor no later than the time it makes its statement available on the website. The business which may be dealt with at the AGM includes any statement that the Company has been required to publish on its website.

14.   Under section 319A of the Companies Act 2006, the Company must, subject to limited exceptions, answer any question relating to the business being dealt with at the AGM which is put by a shareholder attending the AGM. Information relating to the AGM which the Company is required by the Companies Act 2006 to publish on a website in advance of the meeting may be viewed at www.osb.co.uk/ investors/shareholder-services/agm-information/. You may not use any electronic address provided in this notice to communicate with the Company for any purposes other than those expressly stated.

15.   As at 27 March 2020 (being the latest practicable date before the publication of this document), the Company’s issued share capital consisted of 446,201,355 ordinary shares, carrying one vote each. The Company did not hold any shares in treasury at that date. Therefore as at 27 March 2020 the total voting rights in the Company were 446,201,355.

APPENDIX
Director Biographies
Noël Harwerth*
Senior Independent Director

Noël was appointed to the Board and the position of Senior Independent Director in October 2019.

Member of the Group Nomination and Governance, Group Remuneration and Group Risk Committees.

Noël has extensive experience in both the public sector with government bodies and the private sector with global banking companies, which brings valuable insight to Boardroom debate.

Noël was appointed to the Board of CCFS in June 2017 and was its Senior Independent Director from August 2017. Noël is a non-executive director of Scotiabank Europe plc and Sirius Minerals plc. She is a former non-executive director of Standard Life Aberdeen plc and RSA Insurance Group plc, prior to which she held a variety of senior roles with Citicorp for 15 years, latterly serving as the Chief Operating Officer of Citibank International.

Noël’s prior non-executive roles include GE Capital Bank Limited, Sumitomo Mitsui Banking Corporation Europe Avocet Mining, Alent plc, Corus, Logica, The London Metal Exchange and Standard Life Assurance Limited.

Rajan Kapoor*
Non-Executive Director

Rajan was appointed to the Board and the position of Chair of the Group Audit Committee in October 2019.

Chair of the Group Audit Committee and member of the Board Integration, Group Remuneration: Group Risk and Group Models and Ratings Committees.

Rajan has wide-ranging experience of all aspects of banking including external reporting, financial planning and analysis, asset and liability management, taxation and stress testing. He also has extensive experience of financial and regulatory reporting in the UK and US with a strong background in internal financial controls, governance and compliance.     

Rajan was appointed to the Board of CCFS in September 2016. He was Financial Controller of the Royal Bank of Scotland (RBS) Group and held a number of senior finance positions in a 28-year career with RBS. Rajan is a Fellow of the Institute of Chartered Accountants and of the Chartered Institute of Bankers in Scotland.

David Weymouth
Chairman

David was appointed to the Board in September 2017 and held the position of Chairman until October 2019. He was re-appointed as Chairman on 4 February 2020.

Chair of the Board Integration and of the Group Nomination and Governance Committees; a member of the Group Remuneration Committee.

David has over 40 years’ experience in the financial services industry and has an MBA from the University of Exeter. David was previously Chief Information Officer at Barclays Bank plc and Chief Risk Officer at RSA Insurance Group plc. He sat on the Executive Committee of both companies. He served as a Non-Executive Director of Bank of Ireland (UK) plc. His experience as an executive includes a wide range of senior roles in operations, technology, risk and leadership. David is also Chairman of Mizuho International Plc and his other current Non-Executive directorships include Fidelity International Holdings (UK) Limited and The Royal London Mutual Insurance Society.

David uses his intricate knowledge of the financial services industry to guide and chair the Board effectively.

John Graham Allatt*
Non-Executive Director

Graham was appointed to the Board in May 2014.

Chair of the Group Risk and Group Models and Ratings Committees; a member of the Group Audit Committee.

Graham has significant banking, credit risk and financial services experience. Graham was previously Acting Group Credit Director at Lloyds TSB and Chief Credit Officer at Abbey National. Prior to this, he spent 18 years in the NatWest Group culminating in the role of Managing Director, Credit Risk at NatWest Markets. A Fellow of the Institute of Chartered Accountants, Graham was involved with housing associations for nearly 30 years as Treasurer and Board member in the North of England and in London.
As Chair of the Group Risk Committee, Graham uses his vast experience and knowledge to challenge areas of risk. He participates regularly during discussions as a member of the Group Audit Committee and main Board.

Sarah Hedger*
Non-Executive Director

Sarah was appointed to the Board on 1 February 2019.

Member of Group Audit, Board Integration and Group Remuneration Committees.

Sarah has significant capital management and mergers and acquisitions experience in financial services. She is a qualified chartered accountant. Sarah previously held leadership positions at General Electric for twelve years to March 2017 in its Corporate, Aviation and Capital business development teams, leaving General Electric as Leader of Business Development and M&A for its global GE Capital division. Before General Electric, she worked at Lazard & Co., Limited for 11 years, leaving as Director, Corporate Finance and spent five years as an auditor at PwC. Sarah is an independent Non-Executive Director of Balta Group NV, a Belgian company listed on Euronext.

Since joining the Board, Sarah has provided good challenge at Board and Committee meetings.

Mary McNamara*
Non-Executive Director

Mary was appointed to the Board in May 2014.

Chair of Group Remuneration Committee and member of Group Nomination and Governance Committee.

Mary has broad senior management experience in the banking and finance sectors. Mary is a Non-Executive Director Motorpoint plc and until December 2019 of Dignity plc. She was previously CEO of the Commercial Division and Board Director of the Banking Division at Close Brothers Group plc. Prior to that, Mary was Chief Operating Officer of Skandia, the European arm of Old Mutual Group and prior to that, Mary spent 17 years at GE Capital, running a number of businesses including GE Fleet Services Europe and GE Equipment Finance.

Mary uses her broad experience as a member of a number of Committees. She chairs the Group Remuneration Committee and is an active participant in all meetings, ensuring that all points are considered.

Andrew Golding
Chief Executive Officer

Andy was appointed to the Board in December 2011.

Member of the Board Integration Committee.

Andy has over 30 years’ experience in financial services. Andy was previously CEO of Saffron Building Society, where he had been since 2004. Prior to that he held senior positions at NatWest, John Charcol and Bradford & Bingley. Andy currently holds a number of posts with industry institutions including membership of the UK Finance Executive Committee. He is also a Director of the Building Societies Trust and has served as a Non-Executive Director for Northamptonshire NHS and of Kreditech. Andy was a member of the Building Societies Association’s Council and the Financial Conduct Authority’s Small Business Practitioners Panel until October 2019.

Andy has an in-depth knowledge of the business and provides strong leadership and direction.

April Talintyre
Chief Financial Officer

April joined the Bank in May 2012 and was appointed to the Board in June 2012. Member of the Group Models and Ratings Committee.      

April has broad financial services experience. She has been a member of the Institute of Chartered Accountants in England and Wales since 1992.

April was previously an Executive Director in the Rothesay financial services Life pensions insurance business of Goldman Sachs and experience. She has worked for Goldman Sachs International for over 16 years, been a member of the including as an Executive Director in the Controllers Division Institute of Chartered in London and New York. April began her career at KPMG in a Accountants in general audit department.

April has a thorough knowledge of the business, particularly, of finance and risk areas.

*      Independent Non-Executive Director